Thymoglobulin (T) use with Busulfan-Fludarabine (Bu-Flu) for allogeneic transplantation in AML and MDS influences differential effects on outcomes between MRD and MUD donor sources and demonstrates a dose-related impact

Authors

Amir Toor MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

3-2016

Volume

51

Issue

1

Published In/Presented At

Physicians Poster Sessions. Bone Marrow Transplant 51 (Suppl 1), S110–S313 (2016). https://doi.org/10.1038/bmt.2016.48

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article